{"article":{"annotation":{"article_id":"lilly-third-quarter-2026-revenue-earnings-outlook","available_at":"2026-10-29T18:13:12.214368Z","geography_revision":"ef6ee0010dda5fe7b240fd514749b43e214c57da73222d2e40ec83b276dd0977","id":"af7ed11c84b4db5611b0d4804ddc0421a5c647b1c322df48eea95220a05eabb9","input_sha256":"041172c0a7ccc1177205d606d0f6801995953b310312f20a581e2c93c62b2bdb","limitations":["Rule-derived subjects are candidates, not verified editorial labels or calibrated model probabilities.","Coverage is distinct from event location. Unknown country/city/coordinates remain absent; no automatic geocoding.","Article geometries keep their stated precision and methodology; reproducing them is not independent coordinate verification."],"method":"controlled-rules-v1","places":[{"admin1":null,"city":null,"coordinate_note":null,"coordinate_reference_system":"OGC:CRS84","coordinate_source":null,"country":"US","evidence":[{"field":"country","language":"en","note":"Explicit preserved editorial country/region; no city or national centroid inferred","source_urls":["https://www.prnewswire.com/news-releases/lilly-reports-third-quarter-2026-financial-results-raises-full-year-guidance-and-highlights-regulatory-progress-across-the-portfolio-302922907.html"]}],"geometry":null,"id":"iso3166-1:US","kind":"country-or-area","labels":{"ar":"الولايات المتحدة الأمريكية","en":"United States of America","es":"Estados Unidos de América","fr":"États-Unis d’Amérique"},"match_status":"candidate","precision":"regional","role":"coverage","uncertainty_m":null}],"rules_sha256":"fb5ad3c27c91cb840f7a0a05f7f64a5cb26ad0374409ff9457f277c7092e22b4","schema_version":1,"subjects":[{"concept_id":"medtop:20000349","confidence":null,"confidence_method":null,"evidence":[{"field":"category+topics","language":"en","note":"Preserved editorial category/topic; broad candidate only","source_urls":["https://www.prnewswire.com/news-releases/lilly-reports-third-quarter-2026-financial-results-raises-full-year-guidance-and-highlights-regulatory-progress-across-the-portfolio-302922907.html"]}],"method":"controlled-rules-v1","rule_id":"business-broad","status":"candidate"},{"concept_id":"medtop:20000178","confidence":null,"confidence_method":null,"evidence":[{"field":"en.title+en.summary","language":"en","note":"Subject suggested from the title or summary: reported third-quarter 2026 revenue","source_urls":["https://www.prnewswire.com/news-releases/lilly-reports-third-quarter-2026-financial-results-raises-full-year-guidance-and-highlights-regulatory-progress-across-the-portfolio-302922907.html"]}],"method":"controlled-rules-v1","rule_id":"corporate-results","status":"candidate"}],"taxonomy_revision":"1f2db31d811fca07e99b16d402c10e2cc2965c9df1c7b41d9be348b40a24e7fb","taxonomy_version":"IPTC Media Topics 2026-Q2"},"api_url":"https://newsverum.com/api/v1/articles/lilly-third-quarter-2026-revenue-earnings-outlook?lang=es","category":"business","content":{"key_points":[],"paragraphs":["Eli Lilly informó el 29 de octubre de unos ingresos de 24.397 millones de dólares en el tercer trimestre de 2026, un 39% más interanual. El beneficio neto declarado fue de 6.451 millones de dólares y el beneficio diluido por acción, de 7,22 dólares, frente a 6,21 dólares un año antes.","El beneficio medido fuera del marco de los PCGA fue de 7,48 dólares por acción, frente a 7,02 dólares. Tanto las cifras declaradas como las métricas fuera del marco de los PCGA incluyeron cargos de investigación y desarrollo en curso adquiridos de 4,57 dólares por acción, frente a 0,71 dólares en el trimestre del año anterior. Por tanto, la medida ajustada no excluye este gasto relacionado con la adquisición.","La empresa elevó su previsión de ingresos para todo el año a 91–92 mil millones de dólares, desde 85–87 mil millones. El rango anual de beneficio medido fuera del marco de los PCGA pasó a 35–36 dólares por acción, frente a 35,50–36,50, ya que los cargos de investigación adquiridos compensaron con creces la mejora de las expectativas subyacentes. Las previsiones son distintas de los resultados ya obtenidos."],"sections":[]},"corrections":[],"country":"US","data":{"blocks":[{"description":{"ar":"نشر الإعلان الرسمي المشار إليه في 29 أكتوبر 2026.","de":"Veröffentlichung der angeführten offiziellen Mitteilung am 29. Oktober 2026.","en":"Publication of the official announcement on 29 October 2026.","es":"Publicación del anuncio oficial citado el 29 de octubre de 2026.","fr":"Publication de l’annonce officielle citée le 29 octobre 2026.","pt":"Publicação do anúncio oficial citado em 29 de outubro de 2026.","tr":"Atıf yapılan resmî duyurunun 29 Ekim 2026’da yayımlanması."},"id":"source-announcement","items":[{"date":"2026-10-29","description":{"ar":"أعلنت Eli Lilly في 29 أكتوبر أن إيرادات الربع الثالث من 2026 بلغت 24.397 مليار دولار، بزيادة سنوية قدرها 39%. وبلغ صافي الدخل المعلن 6.451 مليار دولار، وربحية السهم المخففة 7.22 دولارات، مقارنة بـ6.21 دولارات قبل عام.","de":"Eli Lilly meldete am 29. Oktober einen Umsatz von 24,397 Milliarden US-Dollar im dritten Quartal 2026, 39 % mehr als im Vorjahr. Der ausgewiesene Nettogewinn betrug 6,451 Milliarden US-Dollar, der verwässerte Gewinn je Aktie 7,22 US-Dollar gegenüber 6,21 US-Dollar ein Jahr zuvor.","en":"Eli Lilly reported third-quarter 2026 revenue of 24.397 billion dollars on 29 October, up 39% year on year. Reported net income was 6.451 billion dollars, with diluted earnings of 7.22 dollars per share, compared with 6.21 dollars a year earlier.","es":"Eli Lilly informó el 29 de octubre de unos ingresos de 24.397 millones de dólares en el tercer trimestre de 2026, un 39% más interanual. El beneficio neto declarado fue de 6.451 millones de dólares y el beneficio diluido por acción, de 7,22 dólares, frente a 6,21 dólares un año antes.","fr":"Eli Lilly a déclaré le 29 octobre un chiffre d’affaires de 24,397 milliards de dollars au troisième trimestre 2026, en hausse de 39 % sur un an. Le bénéfice net publié s’est établi à 6,451 milliards de dollars et le bénéfice dilué par action à 7,22 dollars, contre 6,21 dollars un an plus tôt.","pt":"A Eli Lilly comunicou em 29 de outubro receitas de 24,397 mil milhões de dólares no terceiro trimestre de 2026, mais 39% em termos homólogos. O lucro líquido reportado foi de 6,451 mil milhões de dólares e os ganhos diluídos por ação foram de 7,22 dólares, contra 6,21 dólares um ano antes.","tr":"Eli Lilly, 29 Ekim’de 2026 üçüncü çeyrek gelirinin yıllık bazda %39 artışla 24,397 milyar dolar olduğunu bildirdi. Raporlanan net kâr 6,451 milyar dolar, seyreltilmiş hisse başına kazanç 7,22 dolardı; bir yıl önce kazanç 6,21 dolardı."},"label":{"ar":"إيرادات Lilly ترتفع 39% مع رفع توقعات المبيعات السنوية","de":"Lilly-Umsatz steigt um 39 %, Jahresumsatzprognose angehoben","en":"Lilly revenue rises 39% as annual sales outlook increases","es":"Los ingresos de Lilly aumentan un 39% y sube la previsión anual de ventas","fr":"Les revenus de Lilly progressent de 39 %, prévision annuelle relevée","pt":"Receitas da Lilly sobem 39% e perspetiva anual de vendas aumenta","tr":"Lilly’nin geliri %39 arttı, yıllık satış tahmini yükseltildi"},"status":"occurred"}],"methodology":{"ar":"يسجل التاريخ يوم نشر المصدر الأولي المشار إليه. وتحدد المقالة الفترات المرجعية الإحصائية والإجراءات المستقبلية المعلنة.","de":"Das Datum gibt den Veröffentlichungstag der angeführten Primärquelle an. Statistische Bezugszeiträume und angekündigte künftige Maßnahmen werden im Artikel benannt.","en":"The date records publication of the cited primary source. Statistical reference periods and announced future actions are identified in the article.","es":"La fecha registra el día de publicación de la fuente primaria citada. El artículo identifica los periodos de referencia estadística y las acciones futuras anunciadas.","fr":"La date correspond au jour de publication de la source primaire citée. Les périodes de référence statistique et les actions futures annoncées sont précisées dans l’article.","pt":"A data regista o dia de publicação da fonte primária citada. O artigo identifica os períodos de referência estatística e as ações futuras anunciadas.","tr":"Tarih, atıf yapılan birincil kaynağın yayımlandığı günü gösterir. İstatistiksel referans dönemleri ve duyurulan gelecek eylemleri haberde belirtilir."},"sourceUrls":["https://www.prnewswire.com/news-releases/lilly-reports-third-quarter-2026-financial-results-raises-full-year-guidance-and-highlights-regulatory-progress-across-the-portfolio-302922907.html"],"title":{"ar":"نشر المصدر","de":"Quellenveröffentlichung","en":"Source publication","es":"Publicación de la fuente","fr":"Publication de la source","pt":"Publicação da fonte","tr":"Kaynak yayını"},"type":"events","updatedAt":"2026-10-29T18:04:40Z"}],"version":1},"data_downloads":[{"formats":{"csv":"https://newsverum.com/api/v1/articles/lilly-third-quarter-2026-revenue-earnings-outlook/data/source-announcement?lang=es&format=csv","json":"https://newsverum.com/api/v1/articles/lilly-third-quarter-2026-revenue-earnings-outlook/data/source-announcement?lang=es&format=json"},"id":"source-announcement"}],"data_types":["events"],"editorial_illustration":{"alt":"Ilustración conceptual de industria, ingeniería y conexiones logísticas.","asset_id":"newsverum-v1-business","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"es","scope":"topic","url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1536.webp","width":1536}],"width":1536},"event_id":"event-e7c2e296-f7cd-525c-b41f-cba7b5ff687e","event_period":"2026-09-30","event_period_basis":"event-or-reference-period","id":"lilly-third-quarter-2026-revenue-earnings-outlook","image":null,"importance":0.6,"language":"es","modified_at":"2026-10-29T18:13:08+00:00","publication_basis":"publication-record","published_at":"2026-10-29T18:13:08+00:00","reading_minutes":2,"region":"world","relations":[],"section_illustration":{"alt":"Ilustración conceptual de industria, ingeniería y conexiones logísticas.","asset_id":"newsverum-v1-business","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"es","scope":"section","url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1536.webp","width":1536}],"width":1536},"slug":"lilly-third-quarter-2026-revenue-earnings-outlook","sources":[{"checkedAt":"2026-10-29","name":"Eli Lilly and Company, issuer release on PR Newswire","publishedAt":"2026-10-29","url":"https://www.prnewswire.com/news-releases/lilly-reports-third-quarter-2026-financial-results-raises-full-year-guidance-and-highlights-regulatory-progress-across-the-portfolio-302922907.html"}],"summary":"Eli Lilly informó el 29 de octubre de unos ingresos de 24.397 millones de dólares en el tercer trimestre de 2026, un 39% más interanual.","text":"Eli Lilly informó el 29 de octubre de unos ingresos de 24.397 millones de dólares en el tercer trimestre de 2026, un 39% más interanual.\n\nEli Lilly informó el 29 de octubre de unos ingresos de 24.397 millones de dólares en el tercer trimestre de 2026, un 39% más interanual. El beneficio neto declarado fue de 6.451 millones de dólares y el beneficio diluido por acción, de 7,22 dólares, frente a 6,21 dólares un año antes.\n\nEl beneficio medido fuera del marco de los PCGA fue de 7,48 dólares por acción, frente a 7,02 dólares. Tanto las cifras declaradas como las métricas fuera del marco de los PCGA incluyeron cargos de investigación y desarrollo en curso adquiridos de 4,57 dólares por acción, frente a 0,71 dólares en el trimestre del año anterior. Por tanto, la medida ajustada no excluye este gasto relacionado con la adquisición.\n\nLa empresa elevó su previsión de ingresos para todo el año a 91–92 mil millones de dólares, desde 85–87 mil millones. El rango anual de beneficio medido fuera del marco de los PCGA pasó a 35–36 dólares por acción, frente a 35,50–36,50, ya que los cargos de investigación adquiridos compensaron con creces la mejora de las expectativas subyacentes. Las previsiones son distintas de los resultados ya obtenidos.","title":"Los ingresos de Lilly aumentan un 39% y sube la previsión anual de ventas","topics":[],"translations":[{"api_url":"https://newsverum.com/api/v1/articles/lilly-third-quarter-2026-revenue-earnings-outlook?lang=tr","language":"tr","url":"https://newsverum.com/tr/news/lilly-third-quarter-2026-revenue-earnings-outlook"},{"api_url":"https://newsverum.com/api/v1/articles/lilly-third-quarter-2026-revenue-earnings-outlook?lang=en","language":"en","url":"https://newsverum.com/en/news/lilly-third-quarter-2026-revenue-earnings-outlook"},{"api_url":"https://newsverum.com/api/v1/articles/lilly-third-quarter-2026-revenue-earnings-outlook?lang=ar","language":"ar","url":"https://newsverum.com/ar/news/lilly-third-quarter-2026-revenue-earnings-outlook"},{"api_url":"https://newsverum.com/api/v1/articles/lilly-third-quarter-2026-revenue-earnings-outlook?lang=fr","language":"fr","url":"https://newsverum.com/fr/news/lilly-third-quarter-2026-revenue-earnings-outlook"},{"api_url":"https://newsverum.com/api/v1/articles/lilly-third-quarter-2026-revenue-earnings-outlook?lang=es","language":"es","url":"https://newsverum.com/es/news/lilly-third-quarter-2026-revenue-earnings-outlook"},{"api_url":"https://newsverum.com/api/v1/articles/lilly-third-quarter-2026-revenue-earnings-outlook?lang=de","language":"de","url":"https://newsverum.com/de/news/lilly-third-quarter-2026-revenue-earnings-outlook"},{"api_url":"https://newsverum.com/api/v1/articles/lilly-third-quarter-2026-revenue-earnings-outlook?lang=pt","language":"pt","url":"https://newsverum.com/pt/news/lilly-third-quarter-2026-revenue-earnings-outlook"}],"url":"https://newsverum.com/es/news/lilly-third-quarter-2026-revenue-earnings-outlook"},"version":"1"}